InsiderTrades

Form 4 for VRTX Vertex Pharmaceuticals

Accepted 2022-02-28 00:00:00 ET · period of report 2022-02-24 · accession 0000899243-22-008109 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2022-02-28 2022-02-24 VRTX ALTSHULER DAVID EVP, CSO, Gbl Research F - Tax $227.86 -6,038 43.6K -12% -$1.38M
M 2022-02-28 2022-02-25 VRTX ALTSHULER DAVID EVP, CSO, Gbl Research S - Sale $230.98 -7,572 42.6K -15% -$1.75M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-24 F D 6,038 $227.86 43,649 D — —
2 Common Common Stock 2022-02-25 S D 560 $232.68 36,077 D — — (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $232.68 (range $232.43 to $232.87).
3 Common Common Stock 2022-02-25 S D 2,784 $231.64 36,637 D — — (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $231.64 (range $231.08 to $232.07).
4 Common Common Stock 2022-02-25 S D 3,188 $230.62 39,421 D — — (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $230.62 (range $230.07 to $231.05).
5 Common Common Stock 2022-02-25 S D 1,040 $229.41 42,609 D — — (F3) Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F2) Open market sales reported on this line occurred at a weighted average price of $229.41 (range $228.91 to $229.81).